Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Current Deferred Revenue (2016 - 2025)

Sensus Healthcare (SRTS) has 10 years of Current Deferred Revenue data on record, last reported at $648000.0 in Q3 2025.

  • For Q3 2025, Current Deferred Revenue fell 5.54% year-over-year to $648000.0; the TTM value through Sep 2025 reached $648000.0, down 5.54%, while the annual FY2024 figure was $541000.0, 17.66% down from the prior year.
  • Current Deferred Revenue reached $648000.0 in Q3 2025 per SRTS's latest filing, up from $529000.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $1.8 million in Q1 2021 and bottomed at $529000.0 in Q2 2025.
  • Average Current Deferred Revenue over 5 years is $956631.6, with a median of $808000.0 recorded in 2023.
  • Peak YoY movement for Current Deferred Revenue: tumbled 42.89% in 2023, then surged 41.28% in 2024.
  • A 5-year view of Current Deferred Revenue shows it stood at $1.4 million in 2021, then tumbled by 41.98% to $832000.0 in 2022, then dropped by 21.03% to $657000.0 in 2023, then decreased by 17.66% to $541000.0 in 2024, then increased by 19.78% to $648000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Current Deferred Revenue were $648000.0 in Q3 2025, $529000.0 in Q2 2025, and $550000.0 in Q1 2025.